Discussion of off-target and tentative genomic findings may sometimes be necessary to allow evaluation of their clinical significance

We discuss a case where clinical genomic investigation of muscle weakness unexpectedly found a genetic variant that might (or might not) predispose to kidney cancer. We argue that despite its off-target and uncertain nature, this variant should be discussed with the man who had the test, not because...

Полное описание

Сохранить в:  
Библиографические подробности
Главные авторы: Horton, Rachel H. (Автор) ; Macken, William L. (Автор) ; Pitceathly, Robert D. S. (Автор) ; Lucassen, Anneke (Автор)
Формат: Электронный ресурс Статья
Язык:Английский
Проверить наличие: HBZ Gateway
Interlibrary Loan:Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany)
Опубликовано: 2024
В: Journal of medical ethics
Год: 2024, Том: 50, Выпуск: 5, Страницы: 295-298
Online-ссылка: Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000caa a22000002c 4500
001 1918777268
003 DE-627
005 20250301054332.0
007 cr uuu---uuuuu
008 250228s2024 xx |||||o 00| ||eng c
024 7 |a 10.1136/jme-2023-109108  |2 doi 
035 |a (DE-627)1918777268 
035 |a (DE-599)KXP1918777268 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Horton, Rachel H.  |e VerfasserIn  |0 (orcid)0000-0001-6080-6354  |4 aut 
245 1 0 |a Discussion of off-target and tentative genomic findings may sometimes be necessary to allow evaluation of their clinical significance 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a We discuss a case where clinical genomic investigation of muscle weakness unexpectedly found a genetic variant that might (or might not) predispose to kidney cancer. We argue that despite its off-target and uncertain nature, this variant should be discussed with the man who had the test, not because it is medical information, but because this discussion would allow the further clinical evaluation that might lead it to becoming so. We argue that while prominent ethical debates around genomics often take ‘results’ as a starting point and ask questions as to whether to look for and how to react to them, the construction of genomic results is fraught with ethical complexity, although often couched as a primarily technical problem. We highlight the need for greater focus on, and appreciation of, the ethical work undertaken daily by scientists and clinicians working in genomic medicine and discuss how public conversations around genomics need to adapt to prepare future patients for potentially uncertain and unexpected outcomes from clinical genomic tests. 
700 1 |a Macken, William L.  |e VerfasserIn  |4 aut 
700 1 |a Pitceathly, Robert D. S.  |e VerfasserIn  |4 aut 
700 1 |e VerfasserIn  |0 (DE-588)1078752737  |0 (DE-627)839334400  |0 (DE-576)451674707  |4 aut  |a Lucassen, Anneke 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 50(2024), 5, Seite 295-298  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnas 
773 1 8 |g volume:50  |g year:2024  |g number:5  |g pages:295-298 
856 |u https://jme.bmj.com/content/medethics/early/2023/06/19/jme-2023-109108.full.pdf  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [deprecated] 
856 4 0 |u https://doi.org/10.1136/jme-2023-109108  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://jme.bmj.com/content/50/5/295  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4675092284 
LOK |0 003 DE-627 
LOK |0 004 1918777268 
LOK |0 005 20250228103402 
LOK |0 008 250228||||||||||||||||ger||||||| 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixzo  |a ixrk 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw